Yanghao Chen

USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes

Bozhi Ye, Hao Zhou, Yanghao Chen et al. · Circulation Research · 2023 · 103 citations · Full text

GSDMD Mediates LPS-Induced Septic Myocardial Dysfunction by Regulating ROS-dependent NLRP3 Inflammasome Activation

Shanshan Dai, Bozhi Ye, Lingfeng Zhong et al. · Frontiers in Cell and Developmental Biology · 2021 · 75 citations · Full text

Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation

Chengyi Dai, Wu Luo, Yanghao Chen et al. · Phytomedicine · 2022 · 22 citations

Inflammation, Cardiomyopathy, Heart Failure +8

Integrated Analysis of circRNA-miRNA-mRNA ceRNA Network in Cardiac Hypertrophy

Yanghao Chen, Lingfeng Zhong, Hong Xia et al. · Frontiers in Genetics · 2022 · 18 citations · Full text

Systems Biology, Cardiac Hypertrophy, Genetics +12

Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway

Bozhi Ye, Xudong Chen, Yanghao Chen et al. · Phytomedicine · 2022 · 17 citations

Metabolic Syndrome, Cardiomyopathy, Signal Transduction +13